Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSsYuze Zhao, Huixia Zheng, Weiping Li et al.|Scientific Reports|2024Cited by 8
Oral low-dose cyclophosphamide with endocrine therapy through effects on Tregs in TLSs may improve clinical response in elderly metastatic breast cancer patientsYuze Zhao, Huixia Zheng, Shuo Wang et al.|Research Square|2023Cited by 0